Polish Survey on the Efficacy of the Hypercholesterolemia Treatment
Completed
- Conditions
- Hypercholesterolemia
- Registration Number
- NCT01243255
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defined as achievement of the LDL cholesterol level goals according to the European Society of Cardiology 2007 guidlines.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
- Patients on lipid lowering drug treatment
- Lipid lowering drug treatment lasting at least 3 months
- No lipid lowering drug/dose change for a minimum 6 weeks prior to enrolment to the study
Exclusion Criteria
- Lack of patient's signed informed consent form
- Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method establish the proportion of patients on lipid lowering pharmacological treatment reaching the LDL-C goals according to ESC 2007 guidelines in general. whole study procedure takes place during the one, single patient's visit
- Secondary Outcome Measures
Name Time Method identify determinants (patient and physician characteristics) for undertreatment of hypercholesterolemia. whole study procedure takes place during the one, single patient's visit establish the proportion of patients on lipid lowering pharmacological treatment in primary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population whole study procedure takes place during the one, single patient's visit establish the proportion of patients on lipid lowering pharmacological treatment in secondary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population whole study procedure takes place during the one, single patient's visit